Literature DB >> 9731714

Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research.

W Kalow1, B K Tang, L Endrenyi.   

Abstract

Twin studies are useful devices to determine the heritability of persistent but variable characteristics that tend to differ among individuals. Drug responses are not persistent affairs; they are temporary characteristics. One therefore may ask whether twin studies are necessary to assess the genetic element in pharmacological responsiveness. To measure the genetic component contributing to their variability, it seems logical to investigate the response variation by repeated drug administration to given individuals, and to compare the variability of the responses within and between individuals. We attempt here to describe a theoretical background of this venture, and to show some results of the exercise. Potential sources of error or uncertainty are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731714     DOI: 10.1097/00008571-199808000-00001

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  72 in total

1.  Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors:  Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo.

Authors:  J T Larsen; L L Hansen; K Brosen
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 3.  Individual response to treatment: is it a valid assumption?

Authors:  Stephen Senn
Journal:  BMJ       Date:  2004-10-23

Review 4.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 5.  Second malignancies after multiple myeloma: from 1960s to 2010s.

Authors:  Anish Thomas; Sham Mailankody; Neha Korde; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2012-02-06       Impact factor: 22.113

6.  Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.

Authors:  C A Fernandez; C Smith; W Yang; R Lorier; K R Crews; N Kornegay; J K Hicks; C F Stewart; J D Kawedia; L B Ramsey; C Liu; W E Evans; M V Relling; U Broeckel
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

7.  A genome-wide association study of carotid atherosclerosis in HIV-infected men.

Authors:  Sadeep Shrestha; Marguerite R Irvin; Kent D Taylor; Howard W Wiener; Nicholas M Pajewski; Talin Haritunians; Joseph A C Delaney; Morris Schambelan; Joseph F Polak; Donna K Arnett; Yii-Der Ida Chen; Carl Grunfeld
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

Review 8.  Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

Authors:  G Zaza; S Granata; F Sallustio; G Grandaliano; F P Schena
Journal:  Clin Exp Immunol       Date:  2009-11-24       Impact factor: 4.330

Review 9.  Cancer pharmacogenomics in children: research initiatives and progress to date.

Authors:  Shahrad Rod Rassekh; Colin J D Ross; Bruce C Carleton; Michael R Hayden
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients.

Authors:  T Ashavaid; H Raje; K Shalia; B Shah
Journal:  Indian J Nephrol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.